Quizartinib

CAS No. 950769-58-1

Quizartinib ( AC-220;AC220 )

Catalog No. M16800 CAS No. 950769-58-1

Quizartinib (AC220) is a potent, selective, second-generation FLT3 inhibitor with Kd of 1.6 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 49 In Stock
10MG 65 In Stock
25MG 97 In Stock
50MG 117 In Stock
100MG 192 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Quizartinib
  • Note
    Research use only, not for human use.
  • Brief Description
    Quizartinib (AC220) is a potent, selective, second-generation FLT3 inhibitor with Kd of 1.6 nM.
  • Description
    Quizartinib (AC220) is a potent, selective, second-generation FLT3 inhibitor with Kd of 1.6 nM, inhibits Wt FLT3 and FLT3-ITD autophosphorylation in MV4-11cell with IC50 of 4.2 and 1.1 nM, respectively; displays excellent kinase selectivity in a KinomeScan panel of 402 kinase binding assays, also potently inhibits PDGFRA, PDGFRB and RET; inhibits MV4-11 cell proliferarion with IC50 of 0.56 nM, demonstrates antitumor efficacy in the MV4-11 tumor xenograft model.Blood Cancer Phase 3 Clinical
  • Synonyms
    AC-220;AC220
  • Pathway
    Tyrosine Kinase
  • Target
    FLT3
  • Recptor
    FLT3(ITD);FLT3(WT);FLT3
  • Research Area
    Cancer
  • Indication
    Blood cancer

Chemical Information

  • CAS Number
    950769-58-1
  • Formula Weight
    560.67
  • Molecular Formula
    C29H32N6O4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 33 mg/mL
  • SMILES
    CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1
  • Chemical Name
    Urea, N-[5-(1,1-dimethylethyl)-3-isoxazolyl]-N'-[4-[7-[2-(4-morpholinyl)ethoxy]imidazo[2,1-b]benzothiazol-2-yl]phenyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zarrinkar PP, et al. Blood. 2009 Oct 1;114(14):2984-92.
2. Chao Q, et al. J Med Chem. 2009 Dec 10;52(23):7808-16.
3. Pratz KW, et al. Blood. 2010 Feb 18;115(7):1425-32.
4. Gunawardane RN, et al. Mol Cancer Ther. 2013 Apr;12(4):438-47.
molnova catalog
related products
  • KIN1148

    KIN1148 is a novel small-molecule adjuvant that acts through the RIG-I pathway and IRF-3 transcription factor to stimulate inN/Ate immunity and protection following viral infection.

  • Gilteritinib

    A potent FLT3/AXL inhibitor with IC50 of 0.73 nM/0.29 nM respectively.

  • Tetrahydrocoptisine

    Tetrahydrocoptisine has effective effects in suppressing inflammation. Tetrahydrocoptisine possesses a protective effect on LPS-induced ALI through inhibiting of NF-κB signaling pathways, which may involve the inhibition of pulmonary inflammatory process.